CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed Heart Failure Outcomes With Volume-Guided Management Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block Ejection Fraction Pros and Cons: JACC State-of-the-Art Review Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week

Clinical TrialFebruary 6, 2018, Volume 137, Issue 6

JOURNAL:Circulation Article Link

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

M .Kosiborod, CVD-REAL Investigators and Study Group. Keywords: SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

FULL TEXT PDF